More Syntara Limited news Syntara LimitedASX: SNT Antifibrotic LOXL2 Program Clears Preclinical Development Sep 6, 2017 at 2:58 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
